Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062816
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2003-06-16
Brief Title:
Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C HCV Patients Not Responding Adequately to the Two Drugs
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Organization Data
Organization:
Ionis Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ISIS 14803-CS3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ionis Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None